Join our new priority response service
Complex regulatory challenges for lab grown ingredients
New QP loyalty scheme launched
Diversity & Inclusion
Insights & resources
Quality risk management is a core requirement of the Annex 1 revision, with regulators nudging the industry towards adopting a proactive approach to risk assessment.
This webinar considers the appropriate areas to assess, including contamination control and sterility assurance.
Dr. Tim Sandle has over twenty-five years’ experience of microbiological research and biopharmaceutical processing. He is a member of several editorial boards and he has written over six hundred book chapters, peer reviewed papers and technical articles relating to microbiology. Dr. Sandle works for a pharmaceutical manufacturer in the UK, and is a visiting tutor at both the University of Manchester and UCL.
Switchboard: +44 (0)118 918 4000
+44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.